Skip to content

Pharma.Tips

Unlocking Pharma's Secrets: Your Ultimate Guide to Pharmaceutical Success!

  • Home
  • About Us
  • Contact

Topical & Dermatological Dosage Forms

  • Home
  • DOSAGE FORMS
  • Topical & Dermatological Dosage Forms
  • Page 3

Assay Oos in cream manufacturing: cleaning validation and worst-case selection

The first step in addressing assay OOS in cream manufacturing is to identify any symptoms or signals that may indicate underlying issues. Specifically, these signals may include:Click to read the…

Cleaning Validation Failure after excipient change: GMP investigation and CAPA strategy

Cleaning validation failures manifest through specific symptoms, which may include:Click to read the full article.

Assay Oos during bulk hold: GMP investigation and CAPA strategy

Symptoms or signals indicating possible issues with the assay during bulk hold can emerge from various sources within the manufacturing process. Observations may include:Click to read the full article.

Assay Oos after excipient change: packaging compatibility and stability justification

The identification of symptoms indicating a potential OOS scenario is the first step in any investigation. Symptoms may manifest in various ways, including:Click to read the full article.

Emulsion Inversion during bulk hold: cleaning validation and worst-case selection

Identifying the symptoms of emulsion inversion is the first step in any investigative process. Common signals that may indicate a problem include:Click to read the full article.

Tube Leakage Complaint after excipient change: packaging compatibility and stability justification

The first step in responding to a tube leakage complaint is recognizing the symptoms. Signals may arise from several sources:Click to read the full article.

Ph Drift during method transfer: complaint trending and risk-based actions

Identifying signals of pH drift during method transfer is the first step in any investigation. Common symptoms may include:Click to read the full article.

Assay Oos during bulk hold: packaging compatibility and stability justification

Symptoms of assay OOS during bulk hold phases may manifest in various ways, starting with the detection of unexpected results during routine testing. Specific signals may include:Click to read the…

Tube Leakage Complaint in cream manufacturing: packaging compatibility and stability justification

The first step in addressing tube leakage complaints is to identify specific symptoms that signal a problem. Symptoms can originate during various stages of the production process, storage, or even…

Phase Separation in cream manufacturing: GMP investigation and CAPA strategy

Detection of phase separation can occur at various stages during cream manufacturing. Common symptoms include:Click to read the full article.

Cleaning Validation Failure during method transfer: cleaning validation and worst-case selection

The initial signs of a cleaning validation failure may surface in various forms, often requiring prompt detection and action. Some symptoms to monitor include:Click to read the full article.

Viscosity Drift during method transfer: how to document deviations for FDA/EMA

Recognizing the symptoms of viscosity drift is essential in ensuring that production runs smoothly and meets specified guidelines. Key signals that may indicate a viscosity problem include:Click to read the…

Posts pagination

Previous 1 2 3 4 5 Next

Quick Guide

  • Dosage Forms & Drug Delivery Systems
    • Solid Oral Dosage Forms (Tablets, Capsules)
    • Liquid Oral Dosage Forms (Syrups, Suspensions)
    • Parenteral Dosage Forms (Injectables)
    • Topical & Dermatological Dosage Forms
    • Ophthalmic Dosage Forms
    • Otic Dosage Forms
    • Inhalation & Nasal Dosage Forms
    • Transdermal Drug Delivery Systems
    • Rectal & Vaginal Dosage Forms
    • Dental Dosage Forms
    • Aerosol Formulations
    • Advanced & Novel Drug Delivery Systems
    • Miscellaneous / Combination Drug Products
  • Product Types & Therapeutic Categories
    • Active Pharmaceutical Ingredients (APIs)
    • Finished Pharmaceutical Products (FPPs)
    • Biologics
    • Biosimilars
    • Advanced Therapy Medicinal Products (ATMPs)
    • Oncology Products
    • Hormonal Products
    • Orphan Drugs
    • Radiopharmaceuticals
    • Controlled Substances & Schedule Drugs
    • Ophthalmic & Otic Products
    • Veterinary Medicines
    • Medical Devices
    • Nutraceuticals & Dietary Supplements
    • Herbal & Ayurvedic Products
    • Cosmetic & Cosmeceutical Products
  • Manufacturing Defects & Product Failures
    • Tablet Manufacturing Defects
    • Capsule Manufacturing Defects
    • Injectable Product Defects
    • Ointment & Cream Defects
    • Suspension & Syrup Defects
    • Dry Powder Inhaler (DPI) Defects
    • Transdermal Patch Defects
    • Primary Packaging Defects
    • Secondary & Tertiary Packaging Defects
    • Stability-Induced Product Defects
  • Deviation & Failure Case Studies
    • Manufacturing Deviation Case Studies
    • QC Laboratory Deviations
    • Environmental Monitoring Deviations
    • Sterility & Contamination Deviations
    • Data Integrity Breach Case Studies
    • Validation & Qualification Deviations
    • Warehouse & Storage Deviations
    • Packaging & Labeling Deviations
    • Cleaning & Cross-Contamination Deviations
    • Training & Documentation Deviations
  • Equipment & Instrumentation Troubleshooting
    • Tablet Compression Machine Issues
    • Capsule Filling Machine Issues
    • Granulation Equipment (FBD, RMG) Issues
    • Coating Equipment Problems
    • Filling Line Equipment Problems
    • Autoclave & Depyrogenation Tunnel Issues
    • Blister & Cartoning Machine Issues
    • Labeling & Printing Machine Faults
    • HPLC / GC / UHPLC Equipment Faults
    • HVAC & Cleanroom Troubleshooting
  • Process Optimization & Manufacturing Excellence
    • Compression Process Optimization
    • Granulation Process Optimization
    • Blending Uniformity Improvement
    • Capsule Filling Optimization
    • Solution & Suspension Preparation Optimization
    • Sterile Filtration & Filling Optimization
    • Drying Process Optimization (FBD, Tray Dryer)
    • Coating Efficiency & Uniformity
    • Yield Improvement Strategies
    • Cleaning Cycle Time Reduction
  • Functional Areas in Pharma Operations
    • Manufacturing & Production
    • Quality Assurance (QA)
    • Quality Control (QC)
    • Regulatory Affairs
    • Research & Development (R&D)
    • Validation & Qualification
    • Engineering & Maintenance
    • Packaging Development
    • Stability Studies
    • Supply Chain & Logistics
    • Clinical & Pharmacovigilance
    • Information Technology (IT)
    • Environment, Health & Safety (EHS)
    • Training & HR in GMP Environment
    • Intellectual Property Management (IPR)
    • Project Management
    • Corporate Compliance & Audit Readiness
  • Regulatory Compliance & Quality Systems
    • Good Manufacturing Practices (GMP)
    • WHO GMP Compliance
    • WHO Prequalification (PQ)
    • Good Laboratory Practices (GLP)
    • Good Clinical Practices (GCP)
    • Good Documentation Practices (GDP / ALCOA+)
    • Data Integrity Compliance
    • Validation & Qualification Compliance
    • Audit Readiness & Regulatory Inspections
    • Electronic Records & Electronic Signatures (ERES)
    • Quality Management System (QMS)
    • Regulatory Submissions & Dossiers
    • Serialization & Traceability
    • Import / Export Regulatory Compliance
    • Environmental, Health & Safety Regulations
    • ICH Guidelines & Global Frameworks
    • Controlled Substances Regulations
    • Medical Device Regulatory Compliance
  • Pharmaceutical Research & Drug Development
    • Drug Discovery
    • Preclinical Research
    • Pharmaceutical Research Methodologies
    • Formulation Development
    • Process Development
    • Scale-Up & Tech Transfer
  • Raw Materials & Excipients Management
    • API Quality & Variability Issues
    • Excipient Selection & Compatibility
    • Vendor Qualification & Audits
    • Raw Material Sampling Errors
    • Material Storage & Shelf-Life Control
    • Change Management for Raw Materials
    • Pharmacopoeial Compliance (USP/EP/IP)
    • Material Traceability & Mix-Up Prevention
    • Nitrosamine Risk in Raw Materials
  • Pharmaceutical Packaging Systems
    • Primary Packaging Material Selection
    • Container Closure Integrity (CCI)
    • Blister vs Bottle Packaging Decisions
    • Extractables & Leachables (E&L)
    • Child-Resistant & Senior-Friendly Packaging
    • Cold Chain Packaging Systems
    • Packaging for Sterile Products
    • Artwork Control & Regulatory Review
    • Packaging Line Design & Scale-Up
  • Cleaning, Contamination & Cross-Contamination Control
    • Cleaning Validation Fundamentals
    • Worst-Case Product Selection
    • Residue Limit Calculations (MACO)
    • Detergent Selection & Residue Control
    • Campaign Manufacturing Risks
    • Shared Facility Risk Management
    • Visual Inspection Failures
    • Swab vs Rinse Sampling Issues
    • Cleaning Deviations & CAPA
  • Data Integrity & Digital Pharma Operations
    • ALCOA+ Principles Explained Practically
    • Audit Trail Review Failures
    • Spreadsheet & Excel Data Integrity
    • LIMS Data Integrity Issues
    • CDS (Chromatography Data System) Risks
    • User Access & Privilege Control
    • Backup, Archival & Data Retention
    • Hybrid Paper–Electronic Systems
    • Data Integrity During Inspections
  • Validation, Qualification & Lifecycle Management
    • Process Validation Stage 1–3
    • Continued Process Verification (CPV)
    • Equipment Qualification Pitfalls
    • Utility Qualification (PW, WFI, HVAC)
    • Cleaning Validation Lifecycle
    • Analytical Method Validation Errors
    • Computer System Validation (CSV/CSA)
    • Revalidation Triggers & Strategy
    • Validation Documentation Best Practices
  • Stability Studies & Shelf-Life Management
    • Stability Study Design Errors
    • OOT & OOS in Stability Studies
    • Climatic Zone Considerations
    • Bracketing & Matrixing Misuse
    • Photostability Study Failures
    • Stability Trending & Statistical Analysis
    • Label Claim Justification
    • Ongoing Stability Program Gaps
    • Regulatory Expectations for Stability
  • Pharmaceutical Quality Systems (Advanced QMS)
    • QMS Design for GMP Compliance
    • Management Review Effectiveness
    • Quality Risk Management (ICH Q9)
    • Change Control System Failures
    • CAPA System Effectiveness
    • Deviation Trending & Metrics
    • Supplier Quality Management
    • Document Control System Design
    • Inspection Readiness Programs
  • Regulatory Inspections & Enforcement Actions
    • FDA Inspection Types & Strategy
    • Form 483 Observations Explained
    • Warning Letter Case Studies
    • Data Integrity Enforcement Trends
    • Consent Decrees & Import Alerts
    • Inspection Preparation Checklists
    • Inspector Interview Handling
    • Mock Audit Execution
    • Post-Inspection Remediation
  • Pharmaceutical Manufacturing Scale-Up & Tech Transfer
    • Lab to Pilot Scale Challenges
    • Pilot to Commercial Scale Risks
    • Tech Transfer Documentation
    • CMOs & CDMOs Tech Transfer
    • Process Robustness at Scale
    • Equipment Equivalency Issues
    • Site-to-Site Transfer Risks
    • Regulatory Filing Impact of Scale-Up
    • Post-Approval Change Management
  • Human Factors, Training & GMP Culture
    • GMP Training Effectiveness
    • Human Error in Manufacturing
    • SOP Design & Usability
    • Shift Handover Failures
    • Operator Qualification Programs
    • Training Documentation Gaps
    • Behavioral GMP Issues
    • Quality Culture Development
    • Management Accountability in GMP
  • Pharmaceutical Engineering & Utilities
    • HVAC Design for GMP Facilities
    • Cleanroom Classification Errors
    • Water Systems (PW/WFI) Issues
    • Compressed Air & Gas Quality
    • Preventive Maintenance Failures
    • Calibration System Weaknesses
    • Facility Layout & Material Flow
    • Utility Excursion Management
    • Engineering Change Control
  • Supply Chain, Warehousing & Distribution
    • GDP for Warehousing
    • Temperature Excursion Management
    • Cold Chain Failures
    • Distribution Qualification
    • Third-Party Logistics Oversight
    • Recall Readiness & Traceability
    • Serialization & Track-and-Trace
    • Import Export Compliance Issues
    • Warehouse Audit Findings
  • Pharma Audits, Risk & Compliance Strategy
    • Internal Audit Program Design
    • Risk-Based Audit Planning
    • Vendor & CMO Audits
    • Audit Observation Classification
    • Audit Response Writing
    • CAPA Risk Prioritization
    • Regulatory Intelligence & Trends
    • Compliance Governance Models
    • Corporate Quality Strategy
  • Emerging Technologies & Future Pharma Operations
    • Continuous Manufacturing
    • PAT & Real-Time Release Testing
    • AI & Automation in Pharma
    • Digital Twins in Manufacturing
    • Paperless GMP Systems
    • Advanced Analytics for Quality
    • Smart Factories & Pharma 4.0
    • Regulatory View on New Technologies
Copyright © 2026 Pharma.Tips Theme: Timely News By Artify Themes.